Skip to Content

Clinical Trial Detail

GOG-3001 Amgen 20101129/ENGOT –ov2/GOG-3001

Patient Information

A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study of AMG 386 With Paclitaxel and Carboplatin as First-line Treatment of Subjects With FIGO Stage III-IV Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancers 

Study Number
GOG-3001 Amgen 20101129/ENGOT –ov2/GOG-3001

Clinical Trial Categories

  • Ovarian Cancer

Location

  • Cone Health Cancer Center at Alamance Regional
    1236 Huffman Mill Rd.
    Burlington, NC 27215
    Main: 336-538-7725

Directions

Large Conference Room: Please enter the building through the door to the right of the main entrance…this door is a direct entrance to our meeting room. The Valet service is operating at our main entrance for our patients.

Also in this Section